The Nedley Depression and Anxiety Recovery Program leaves no stone unturned in determining the exact cause and precise brain chemistry of the patient that can be reversed and fixed. You will get the ...

Christopher Rozell serves on the scientific advisory board and owns shares in Motif Neurotech, Inc. and is a listed inventor on intellectual property related to this work. He receives funding from NIH ...

Using a novel deep brain stimulation (DBS) device capable of recording brain signals, researchers have identified a pattern of brain activity or “biomarker” related to clinical signs of recovery from ...

Heart disease is the number one killer in the US today. Innovations in diagnosis and treatment have significantly improved survival rates after heart attack and more patients are now living longer ...